Table 3

Detection of CAD/Risk Assessment: Without Chest Pain Syndrome or Anginal Equivalent in Patient Populations With Defined Comorbidities

IndicationAppropriateness Score (1–9)
New-Onset or Diagnosed Heart Failure or LV Systolic Dysfunction
14.
  • Moderate CHD risk (Framingham)

  • No prior CAD evaluation

  • Normal LV systolic function

A (7)
15
  • Moderate CHD risk (Framingham)

  • No prior CAD evaluation

  • Abnormal LV systolic dysfunction

U (5)
Valvular Heart Disease Requiring Valve Surgery
16.
  • Moderate CHD risk (Framingham)

I (3)
New-Onset Atrial Fibrillation
17.
  • Low CHD risk (Framingham)

  • Part of the evaluation

I (2)
18.
  • Moderate to high CHD risk (Framingham)

  • Part of the evaluation

A (7)
Nonsustained Ventricular Tachycardia
19.
  • Moderate to high CHD risk (Framingham)

  • Stress echo using exercise stress only

A (7)
  • The ranking of this indication as inappropriate is different from that given to similar but not identical indications in previously published appropriateness criteria. The ratings were done in accordance with established ACCF methodology. Furthermore, the Technical Panel for each modality operated independently without allowance and with discouragement for intermodality comparisons. Discrepant scores may be related to rating variability, differing Technical Panel composition, maturation of the appropriatness criteria process, or perceived differences in appropriateness.